Tim Mitchison

Scientific Advisor at Ribon Therapeutics

Dr. Mitchison is a systems biologist and a pioneer in the study of cell division and a co-founder of Ribon. He is the Hasib Sabbagh Professor of Systems Biology and Deputy Chair of the Department of Systems Biology at Harvard Medical School (HMS), which he helped found along with the Institute of Chemistry and Cell Biology. Prior to HMS, he was a Professor at University of California, San Francisco. Dr. Mitchison pioneered the use of high-content phenotypic screening that led to identification of novel inhibitors of the mitotic kinesin Eg5/KSP, an anti-cancer target that has led to several Phase III studies. Mitchison is a former Searle scholar, a fellow of the Royal Society, a member of the National Academy of Sciences, and a member of the American Academy of Arts and Sciences. In addition to these honors, he is also a past president of the American Society for Cell Biology.

Dr. Mitchison earned his Ph.D. in Biochemistry and Biophysics from the University of California, San Francisco where he also completed postdoctoral work with Dr. Marc Kirschner. He received a B.A. in Biochemistry from the University of Oxford in England.

Location

Boston, United States

Links


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Ribon Therapeutics

Ribon is a clinical-stage biotechnology company dedicated to the discovery and development of first-in-class small molecule inhibitors to block the fundamental ability of cancer cells to survive under stress.


Industries

Employees

51-200

Links